background
respiratori
syncyti
viru
rsv
lower
respiratori
tract
infect
lri
infanc
consist
associ
increas
risk
childhood
asthma
addit
evid
support
relationship
causal
howev
mechan
rsv
contribut
asthma
develop
understood
inspir
infant
suscept
pulmonari
infect
asthma
follow
rsv
exposur
studi
object
character
host
phenotyp
respons
rsv
infect
infanc
risk
recurr
wheez
asthma
identifi
immun
respons
lung
injuri
pattern
rsv
infect
associ
develop
earli
childhood
wheez
ill
asthma
determin
contribut
specif
rsv
strain
earli
childhood
wheez
asthma
develop
articl
describ
inspir
studi
includ
studi
aim
design
recruit
result
enrol
popul
characterist
methodsdesign
cohort
popul
base
longitudin
birth
cohort
term
healthi
infant
enrol
first
month
life
two
year
period
respiratori
infect
surveil
conduct
novemb
march
first
year
life
survey
administ
everi
two
week
inperson
ill
visit
conduct
infant
met
prespecifi
criteria
respiratori
ill
visit
infant
follow
annual
age
year
assess
primari
endpoint
wheez
ill
nasal
urin
stool
blood
sampl
collect
variou
time
point
throughout
studi
measur
host
viral
factor
predict
wheez
ill
nest
casecontrol
studi
addit
use
address
primari
secondari
hypothes
discuss
inspir
studi
infant
femal
enrol
two
enrol
year
followup
continu
mean
age
enrol
day
winter
viral
season
surveil
survey
carri
result
respiratori
ill
visit
infant
first
year
followup
complet
percent
particip
first
year
enrol
ongo
followup
wheez
childhood
asthma
outcom
inspir
studi
advanc
understand
complex
causal
relationship
rsv
infect
earli
childhood
wheez
asthma
prospect
epidemiolog
studi
consist
demonstr
infant
respiratori
syncyti
viru
rsv
lower
respiratori
tract
infect
lri
increas
risk
earli
childhood
wheez
asthma
also
evid
anim
human
clinic
studi
mild
rsv
infect
may
reduc
risk
asthma
develop
presumpt
modul
pathogen
immun
earli
activ
expans
regulatori
cell
intervent
trial
human
demonstr
prevent
infant
rsv
ill
prevent
recurr
wheez
mechanist
studi
anim
model
provid
proof
concept
plausibl
mechan
rsv
could
caus
asthma
addit
research
demonstr
strain
rsv
associ
clinic
sever
acut
infect
thu
rsv
may
import
organ
modifi
develop
immun
system
differ
depend
sever
host
respons
viru
import
rsv
prevent
modul
host
respons
viral
infect
could
result
new
target
primari
asthma
prevent
inspir
infant
suscept
pulmonari
infect
asthma
follow
rsv
exposur
studi
build
upon
known
link
rsv
lri
wheez
ill
address
unansw
question
role
mild
rsv
infect
decreas
risk
childhood
wheez
ill
host
viral
characterist
associ
wheez
asthma
follow
infant
rsv
infect
yet
predict
infant
rsv
lri
ultim
develop
childhood
asthma
wheez
ill
might
benefit
prevent
earli
viral
infect
inspir
studi
cohort
design
help
understand
complet
spectrum
mild
sever
rsv
ill
contribut
earli
childhood
wheez
asthma
particular
pauciti
studi
outpati
rsv
studi
captur
mild
rsv
infect
longitudin
cohort
specif
design
establish
relationship
host
phenotyp
respons
rsv
infect
first
month
life
risk
recurr
wheez
asthma
identifi
host
immun
respons
determin
rsv
infect
phenotyp
develop
earli
childhood
wheez
asthma
follow
rsv
infect
determin
contribut
specif
rsv
strain
earli
childhood
wheez
asthma
develop
figur
depict
conceptu
framework
studi
built
upon
paper
detail
studi
aim
procedur
recruit
result
inspir
studi
uniqu
birth
cohort
term
healthi
infant
follow
longitudin
infanc
earli
childhood
outcom
wheez
ill
asthma
detail
character
respiratori
ill
infanc
rsv
season
studi
identifi
host
studi
design
test
two
primari
hypothes
sever
rsv
infect
infanc
associ
recurr
wheez
earli
childhood
asthma
severitydepend
manner
indic
host
immun
respons
lung
injuri
associ
infant
rsv
infect
differ
among
infant
develop
recurr
wheez
earli
childhood
asthma
secondari
object
test
hypothesi
specif
rsv
strain
associ
differenti
lri
sever
recurr
wheez
earli
childhood
asthma
determin
associ
viral
infect
uri
mild
lri
sever
allerg
rhiniti
ar
test
interact
allerg
rhinitislaboratori
atopi
smoke
famili
histori
asthma
infant
age
rsv
infect
respiratori
infect
sever
assess
relationship
lri
sever
allerg
rhiniti
within
lri
subgroup
determin
associ
rsv
infect
sever
recurr
wheez
wheez
ill
sever
test
hypothesi
rsv
strain
differ
pattern
cytokin
acut
infect
longitudin
character
airway
microbiom
earli
infanc
infant
rsv
acut
respiratori
ill
ari
year
age
subset
children
n
determin
whether
specif
pattern
airway
microbiom
divers
earli
infanc
prior
rsv
ari
infant
rsv
ari
andor
chang
pattern
health
rsv
ari
associ
respiratori
outcom
sever
rsv
ari
infanc
subsequ
develop
wheez
ill
earli
childhood
determin
whether
specif
pattern
airway
microbi
divers
earli
infanc
prior
rsv
ari
infant
rsv
ari
andor
chang
pattern
health
rsv
ari
associ
pattern
cell
respons
innat
cellular
respons
rsv
stimul
year
subset
infant
address
primari
hypothesi
design
longitudin
observ
birth
cohort
studi
infant
inspir
cohort
enrol
two
year
period
includ
respiratori
ill
surveil
novemb
march
infant
first
year
life
annual
followup
third
fourth
birthday
primari
hypothesi
address
use
nest
casecontrol
studi
particip
within
cohort
enrol
longitudin
follow
term
otherwis
healthi
infant
pediatr
practic
locat
middl
tennesse
selfreferr
research
announc
recruit
area
encompass
urban
suburban
rural
area
infant
meet
elig
criteria
outlin
tabl
approach
time
pediatr
visit
particip
practic
design
infant
whose
birthday
fell
june
st
decemb
st
target
enrol
infant
averag
younger
month
age
winter
viru
season
rsv
infect
like
repres
first
sever
infect
meet
recruit
mileston
assur
suffici
spectrum
diseas
sever
recruit
season
infant
also
enrol
acut
ill
protocol
inform
consent
document
approv
institut
review
board
vanderbilt
univers
medic
center
one
parent
particip
provid
written
inform
consent
particip
studi
inform
consent
document
explain
studi
procedur
use
data
biospecimen
futur
studi
includ
rider
genet
studi
baselin
visit
train
studi
staff
administ
baselin
questionnair
compon
studi
visit
given
tabl
questionnair
includ
demograph
characterist
infant
medic
histori
famili
histori
secondhand
smoke
exposur
daycar
attend
growth
trajectori
factor
known
associ
childhood
asthma
allergi
develop
multipl
biospecimen
collect
differ
purpos
time
point
describ
tabl
urin
sampl
collect
enrol
use
extern
bag
marker
inflamm
lung
injuri
year
infant
stool
sampl
nasal
sampl
also
collect
enrol
infant
nasal
sampl
enrol
collect
insert
filter
paper
pall
corpor
port
washington
ny
nostril
describ
previous
matern
finger
stick
also
collect
year
bank
matern
blood
sampl
assay
vitamin
e
isoform
respiratori
ill
surveil
conduct
winter
viru
season
novemb
march
infant
first
year
life
order
captur
character
infant
acut
respiratori
ill
rsv
season
respiratori
ill
surveil
three
compon
first
parent
instruct
call
research
staff
novemb
march
first
onset
respiratori
symptom
includ
one
follow
runni
nose
congest
wheez
fever
andor
cough
time
screen
respiratori
ill
survey
complet
second
enrol
infant
seen
acut
visit
pediatr
practic
approach
administ
respiratori
ill
survey
third
everi
two
week
novemb
march
parent
receiv
regular
contact
email
secur
survey
telephon
call
complet
respiratori
ill
survey
respiratori
ill
survey
seri
question
respiratori
symptom
time
onset
infant
met
case
definit
respiratori
ill
visit
base
respons
respiratori
ill
surveil
questionnair
parent
indic
one
follow
major
symptom
diagnos
wheez
difficulti
breath
told
babi
posit
rsv
test
two
follow
minor
symptom
diagnos
fever
runni
nosecongest
snotti
nose
cough
ear
infect
otiti
media
hoars
cri
onset
symptom
must
prior
week
past
day
infant
enrol
year
studi
prior
day
infant
enrol
year
studi
chang
symptomdiagnosi
window
made
accommod
miss
respiratori
visit
staf
weekend
infant
met
prespecifi
criteria
respiratori
ill
visit
inperson
visit
perform
either
clinic
pediatr
clinic
research
center
infant
home
visit
includ
brief
physic
exam
element
measur
sever
respiratori
infect
respiratori
rate
oxygen
saturationheart
rate
wheez
chest
retract
chart
review
use
supplement
research
exam
inform
doctor
diagnosi
healthcar
visit
occur
respiratori
symptom
assess
detail
symptom
present
date
onset
addit
nasal
wash
urin
sampl
collect
respiratori
ill
visit
nasal
wash
conduct
use
ml
steril
salin
solut
immedi
place
degre
celsiu
nasal
wash
aliquot
snap
frozen
degre
within
hour
collect
one
year
followup
visit
conduct
month
age
includ
question
respiratori
health
exposur
venipunctur
rsv
serolog
caregiv
refus
venipunctur
blood
abl
drawn
research
staff
collect
blood
toe
finger
stick
consent
given
genet
studi
buffi
coat
sampl
bank
futur
dna
extract
particip
also
ask
collect
household
dust
sampl
wipe
top
doorfram
room
infant
sleep
wipe
dalla
lana
school
public
health
univers
toronto
toronto
canada
return
mail
sampl
use
endotoxinlipopolysaccharid
measur
annual
followup
studi
contact
ongo
take
place
year
year
followup
telephon
survey
includ
intern
studi
asthma
allergi
children
isaac
allerg
diseas
respiratori
diseas
questionnair
third
year
visit
inperson
includ
compon
well
skin
prick
test
aeroallergen
common
region
skin
test
perform
blood
draw
measur
specif
ige
aeroallergen
coprimari
studi
endpoint
recurr
wheez
earli
childhood
asthma
recurr
wheez
defin
age
year
two
wheez
episod
time
period
earli
childhood
asthma
determin
age
four
use
element
isaac
questionnair
children
meet
follow
criteria
age
four
classifi
definit
earli
childhood
asthmat
preval
asthma
symptom
exerciseinduc
wheez
dri
cough
night
physician
diagnosi
parent
report
useprescript
asthma
medic
children
meet
one
two
criteria
consid
probabl
earli
childhood
asthma
respiratori
ill
sever
time
ill
measur
ordin
scale
base
wheez
respiratori
rate
retract
oxygen
satur
heart
rate
modifi
score
deriv
lri
also
dichotom
outcom
lri
versu
uri
use
measur
sever
allerg
rhiniti
ar
diagnosi
also
made
use
element
isaac
questionnair
children
consid
definit
allerg
rhiniti
ar
three
condit
present
age
four
histori
nasal
congest
runni
nose
itchi
wateri
eye
sneez
block
nose
substanti
variabl
symptom
time
season
diagnos
ar
physician
medic
ar
patient
consid
probabl
ar
report
symptom
outlin
diagnos
treat
physician
atop
dermat
diagnosi
confirm
isaac
core
question
atop
dermat
base
list
major
minor
criteria
propos
hanifin
rajka
patient
classifi
definit
atop
dermat
report
ever
itchi
rash
come
goe
least
six
month
diagnos
eczema
physician
document
classifi
probabl
atop
dermat
report
one
two
criteria
atopi
assess
either
posit
skin
prick
allergen
test
aeroallergen
prefer
specif
ige
blood
test
age
year
posit
skin
prick
test
defin
wheal
center
rais
part
mm
greater
one
aeroallergen
histamin
control
posit
salin
control
neg
nonreact
indic
patient
dermatograph
ie
react
irrit
specif
allergen
laboratori
atopi
defin
specif
ige
paul
least
one
common
aeroallergen
perform
blood
specimen
collect
addit
secondari
endpoint
defin
break
coprimari
recurr
wheez
outcom
wellaccept
asthma
phenotyp
includ
transient
earli
wheez
defin
wheez
episod
first
three
year
life
persist
wheez
defin
wheez
first
three
year
beyond
late
onset
wheez
defin
wheez
present
first
three
year
symptom
begin
three
four
year
singleplex
reversetranscript
realtim
pcr
assay
rsv
human
rhinoviru
human
enteroviru
human
ribonucleas
p
rnasep
nasal
wash
perform
accord
publish
protocol
rnasep
serv
endogen
control
specimen
qualiti
specimen
fail
demonstr
rnasep
signal
among
multipl
individu
process
aliquot
deem
indetermin
virus
detect
repetit
test
effici
nucleic
acid
extract
monitor
amplif
rnasep
cultur
humancel
lysat
incorpor
round
specimen
process
result
amplif
reaction
valid
expect
find
water
blank
neg
control
posit
control
deriv
viral
cultur
lysat
adjust
concentr
repres
patient
specimen
includ
pcr
reaction
plate
rsv
igg
antibodi
assess
one
year
four
enzym
immunoassay
eia
one
eia
use
rsv
group
strain
lysat
antigen
one
use
rsv
group
b
strain
lysat
one
use
rsv
group
g
protein
peptid
rsv
aa
ndfhfevfnf
vpcsicsnnp
tcwaickrip
one
use
rsv
group
b
g
protein
peptid
rsv
aa
ddyhfevfnf
vpcsicgnnq
lcksicktip
rsv
serolog
year
one
coupl
viral
identif
rsv
pcr
time
respiratori
ill
use
determin
whether
infant
expos
rsv
addit
biomark
analyz
acut
respiratori
ill
also
serv
primari
endpoint
analys
lung
injuri
host
immun
respons
measur
urin
sampl
collect
acut
respiratori
ill
includ
cysteinyl
leukotrien
hne
prostacyclin
isoprostan
immun
function
biomark
assay
nasal
wash
collect
acut
respiratori
ill
includ
vegf
gcsf
egf
fgf
eotaxin
eotaxin
tarc
lif
tpo
scf
tslp
trail
descript
analysi
infant
demograph
clinic
biolog
measur
perform
use
mean
standard
deviat
median
interquartil
rang
continu
variabl
proport
categor
variabl
first
hypothesi
examin
whether
sever
rsv
infect
associ
risk
earli
childhood
wheez
earli
childhood
asthma
rsv
exposur
determin
confirm
rsv
ill
pcr
andor
posit
rsv
serolog
coprimari
endpoint
recurr
wheez
earli
childhood
asthma
describ
previous
logist
regress
use
estim
odd
ratio
confid
interv
develop
childhood
asthma
recurr
wheez
children
sever
mild
rsv
infect
rel
infect
infanc
crude
or
or
adjust
confound
variabl
deriv
confound
variabl
multipl
logist
regress
model
includ
matern
age
infant
age
first
rsv
infect
gestat
age
secondhand
smoke
sh
infant
sex
famili
histori
allerg
diseas
confound
variabl
consid
includ
detail
home
environ
includ
infant
diet
use
acetaminophen
nsaid
studi
year
gender
famili
histori
asthma
priori
interact
term
includ
model
examin
effect
chang
model
devianc
addit
analys
conduct
assess
model
fit
includ
scatter
plot
squar
standard
pearson
residu
estim
asthma
probabl
patient
covari
pattern
analys
conduct
use
sa
sa
institut
cari
nc
r
http
wwwrprojectorg
test
hypothesi
measur
host
immun
respons
lung
injuri
differ
infant
rsv
ill
develop
recurr
wheez
earli
childhood
asthma
conduct
nest
casecontrol
studi
incid
earli
childhood
asthma
case
follow
infant
rsv
infect
match
rsvinfect
children
develop
recurr
wheez
asthma
two
control
select
case
follow
first
fit
logist
regress
model
asthma
outcom
regress
match
covari
coeffici
model
use
weight
creat
asthma
risk
score
subject
weight
sum
risk
covari
control
frequenc
match
case
base
asthma
risk
score
risk
score
deriv
one
prior
analys
administr
data
set
use
regress
analysi
primari
hypothesi
power
calcul
perform
studi
began
primari
outcom
studi
recurr
wheez
ill
age
rather
asthma
requir
time
followup
allow
grant
fund
period
power
calcul
base
birth
cohort
infant
plu
total
infant
recruit
time
rsv
infect
infanc
total
children
two
third
assum
sever
rsv
diseas
necessit
hospit
onethird
mild
diseas
treat
outpati
basi
anticip
subject
success
follow
measur
asthma
outcom
year
age
power
primari
hypothesi
rsv
exposur
level
infant
lri
uri
rsv
infect
first
year
life
assum
conserv
estim
infant
expos
rsv
develop
asthma
age
year
perform
power
calcul
base
test
null
hypothesi
asthma
preval
affect
infant
rsv
exposur
type
error
probabl
figur
red
curv
show
power
differ
asthma
odd
ratio
infant
rsv
lri
rel
infect
expect
preval
asthma
among
infant
uri
mild
dash
blue
curv
figur
show
asthma
odd
ratio
infant
exposur
vs
mild
infect
preval
recurr
wheez
expect
much
higher
asthma
preval
shown
thu
expect
ampl
power
analysi
anticip
entir
cohort
recurr
wheez
three
year
age
provid
us
consider
power
detect
differ
odd
ratio
figur
power
primari
hypothesi
assess
associ
rsv
exposur
asthma
base
infant
attrit
wheez
attain
asthma
shown
figur
power
calcul
show
least
power
detect
recurr
wheez
rel
risk
greater
less
subgroup
infant
defin
rsv
exposur
assum
follow
primari
hypothesi
nest
casecontrol
studi
preliminari
data
previou
studi
provid
estim
select
biomark
includ
leukotrien
hne
estim
minim
detect
differ
two
side
given
tabl
differ
number
asthma
case
identifi
overview
recruit
present
figur
infant
enrol
infant
first
year
second
year
approach
elig
infant
enrol
agre
particip
common
reason
particip
provid
enrol
interest
n
five
hundr
twentytwo
parent
receiv
brochur
studi
inform
decid
enrol
time
visit
situat
abl
establish
contact
despit
continu
presenc
pediatrician
offic
know
reason
nonenrol
time
public
particip
withdrawn
studi
commonli
due
unexpect
move
middl
tennesse
n
second
common
reason
discomfort
blood
draw
n
will
particip
move
blood
sampl
collect
process
ship
annual
case
report
form
administ
telephon
demograph
characterist
sampl
shown
tabl
approxim
percent
particip
enrol
pediatr
practic
staff
locat
onsit
throughout
studi
remain
visit
perform
vanderbilt
pediatr
clinic
research
center
pcrc
eight
percent
infant
acut
respiratori
infect
time
enrol
among
ageelig
visit
complet
decemb
two
respiratori
season
novemb
march
respiratori
surveil
contact
complet
email
telephon
inperson
individu
individu
never
respond
median
time
contact
day
interquartil
rang
iqr
day
median
number
respons
per
individu
iqr
survey
respond
report
symptom
within
past
day
howev
met
criteria
acut
respiratori
ill
visit
either
major
symptom
minor
symptom
respiratori
ill
visit
complet
infant
nasal
wash
collect
store
infant
one
respiratori
ill
visit
infant
visit
visit
visit
visit
urin
collect
respiratori
ill
visit
infant
respiratori
ill
visit
rsv
posit
base
pcr
nasal
wash
blood
bank
rsv
serolog
test
infant
sampl
time
public
telephon
call
ongo
recruit
first
year
enrol
visit
ongo
infant
enrol
second
year
complet
approxim
followup
visit
first
year
enrol
exclud
withdraw
current
inspir
largest
popul
base
prospect
epidemiolog
studi
spectrum
sever
rsv
infect
ill
assess
relationship
recurr
wheez
ill
asthma
onset
asthma
multifactori
diseas
onset
cours
sever
reflect
combin
effect
developmentspecif
exposur
utero
postnat
host
respons
exposur
rsv
one
ubiquit
exposur
infecti
agent
like
work
differenti
modifi
develop
immun
system
lung
base
specif
strain
sever
infect
host
respons
infect
first
primari
studi
hypothesi
use
entir
cohort
determin
relationship
spectrum
rsv
exposur
sever
infect
risk
wheez
ill
childhood
sever
lri
link
develop
wheez
asthma
littl
known
role
mild
infect
inspir
studi
design
address
gap
knowledg
role
host
immun
respons
lung
injuri
rsv
infect
asthma
incept
understand
viral
strain
differ
contribut
infant
morbid
asthma
risk
done
second
studi
hypothesi
util
nest
casecontrol
design
within
total
cohort
design
identifi
host
immun
lung
injuri
marker
differenti
associ
outcom
wheez
ill
age
eventu
childhood
asthma
age
hypothesi
base
evid
host
respons
associ
increas
risk
sever
rsv
lri
among
infant
sever
rsv
infect
eosinophil
activ
cytokin
elev
compar
nonil
infant
mildli
ill
infant
correl
sever
ill
rsv
lri
cysteinyl
leukotrien
remain
elev
nasal
epithelium
product
genet
variant
associ
postbronchi
wheez
rsv
infect
may
also
caus
harm
remodel
infant
lung
infant
lung
fulli
develop
birth
chang
airway
epithelium
alveolar
continu
first
two
year
life
anim
studi
shown
increas
airway
hyperrespons
decreas
neuron
relax
experiment
rsv
infect
inspir
studi
bridg
known
immun
respons
time
infect
extend
year
outcom
wheez
ill
rsv
strain
infant
inspir
sequenc
determin
strain
differ
associ
acut
infect
morbid
infanc
later
wheez
outcom
prior
studi
infant
rsv
infect
focus
almost
exclus
infant
hospit
rsv
lri
infant
howev
milder
rsv
infect
major
develop
rsv
lri
develop
asthma
sever
lri
clearli
link
develop
asthma
import
unansw
question
whether
mild
rsv
infect
confer
intermedi
risk
may
actual
protect
incept
childhood
asthma
mild
rsv
infect
prime
immun
system
confer
protect
effect
futur
wheez
ill
import
implic
develop
rsv
vaccin
rsv
immunoprophylaxi
thu
compel
reason
focu
develop
new
approach
understand
certain
infant
predispos
develop
viral
lri
children
rsv
lri
develop
subsequ
childhood
asthma
strength
studi
includ
biweekli
surveil
captur
full
spectrum
respiratori
infect
includ
even
mild
infect
regular
surveil
interv
serolog
confirm
infant
infect
identifi
infect
unexpos
locat
research
staff
pediatr
clinic
allow
frequent
contact
particip
throughout
winter
viru
season
also
larg
repositori
bank
urin
sampl
enrol
acut
ill
plasma
sampl
dna
stool
sampl
acut
ill
nasal
wash
baselin
enrol
nasal
filter
paper
sampl
studi
sever
limit
import
consid
first
studi
sampl
select
gener
popul
instead
recruit
particip
pediatr
clinic
citi
nashvil
surround
counti
howev
attempt
enrol
birth
clinic
meet
criteria
studi
cohort
demograph
repres
vari
popul
demograph
reflect
divers
commun
cohort
recruit
surveil
respiratori
ill
occur
full
period
howev
surveil
biweekli
survey
selfreport
ill
may
miss
report
addit
respiratori
ill
visit
may
occur
day
onset
symptom
thu
character
ill
sever
visit
may
reflect
time
ill
sever
although
decid
includ
enrich
sampl
infant
acut
respiratori
infect
emerg
room
hospit
admiss
major
sourc
enrol
mani
particip
abl
fulfil
longitudin
studi
requir
primarili
due
larg
distanc
studi
site
studi
fund
nation
institut
allergi
infecti
diseas
niaid
asthma
allerg
diseas
cooper
research
center
aadcrc
grant
also
support
three
relat
project
investig
key
diseas
mechan
util
sampl
cohort
first
project
aim
identifi
molecular
basi
rsv
strain
differ
associ
mild
sever
rsv
respiratori
infect
collabor
emori
univers
school
medicin
mlm
lja
j
craig
venter
institut
srd
genotyp
rsv
isol
inspir
cohort
order
identifi
rsv
genotyp
associ
bronchiol
sever
childhood
wheez
develop
asthma
second
project
studi
role
pgi
mous
model
respiratori
syncyti
viru
rsv
infect
rsp
ultim
goal
determin
target
therapi
host
immun
respons
could
prevent
treat
sever
rsv
bronchiol
subsequ
develop
asthma
third
project
longitudin
character
infant
earli
childhood
microbiom
health
acut
respiratori
ill
associ
microbi
divers
infant
acut
respiratori
ill
sever
childhood
wheez
outcom
tvh
cr
srd
summari
ongo
studi
answer
import
question
mechan
rsv
caus
acut
long
term
respiratori
morbid
methodolog
paper
outlin
studi
question
address
birth
cohort
inspir
design
address
question
provid
preliminari
enrol
data
uniqu
studi
design
target
infant
born
june
decemb
averag
month
age
rsv
circul
wellcharacter
respiratori
infect
infanc
pois
address
import
question
causal
role
rsv
infect
develop
childhood
wheez
earli
childhood
asthma
addit
care
phenotyp
cohort
rich
biospecimen
repositori
futur
plan
includ
follow
cohort
childhood
asthma
outcom
age
character
host
respons
infect
associ
protect
risk
asthma
understand
associ
risk
factor
includ
host
genet
